jnj-55375515
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2015 (NCT02623491)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Metabotropic glutamate receptor 2MODULATOR
GRM2 modulator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- jnj-55375515
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03405441 | Phase 1 | Jan 2, 2018 | Johnson and Johnson |
| NCT02623491 | Phase 1 | Nov 1, 2015 | Johnson and Johnson |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Johnson and Johnson | For profit | 2 | 2 | 1 | 2015 |
1 organizations
Page 1 / 1